White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effects of Risdiplam for Adults and Children with Spinal Muscular Atrophy

Not recruiting

2 1 1
Investigated Diseases:
- Spinal muscular atrophy
Investigated Drugs:
- Risdiplam
Study on the Safety and Effectiveness of Mirabegron for Children Aged 6 Months to Under 3 Years with Neurogenic Detrusor Overactivity

Not recruiting

3 1 1
Investigated Diseases:
- Hypertonic bladder
- Neurogenic bladder
Investigated Drugs:
- Mirabegron
Study on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors

Not recruiting

3 1 1
Investigated Drugs:
- Apremilast
- Deucravacitinib
Study of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy

Not recruiting

3 1 1 1
Investigated Drugs:
+9
Study on Ilofotase Alfa to Prevent Kidney Damage in Patients Undergoing Open Heart Surgery

Not recruiting

2 1
Investigated Diseases:
- Renal injury
Investigated Drugs:
- Ilofotase Alfa
Study of Venglustat and Imiglucerase for Adult Patients with Gaucher Disease Type 3

Not recruiting

2 1 1 1
Investigated Diseases:
- Gaucher’s disease type I
- Gaucher’s disease type III
Investigated Drugs:
- Imiglucerase
- Venglustat
Study of Elacestrant for Patients with Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer Who Have Not Used CDK4/6 Inhibitors

Not recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:
- Elacestrant
Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
Study on the Effectiveness and Safety of Gemcitabine, Cisplatin, Trastuzumab, and Pembrolizumab for Untreated HER2-Positive Biliary Tract Cancer Patients

Not recruiting

2 1 1 1
Investigated Diseases:
- Gallbladder cancer
- Cholangiocarcinoma
Investigated Drugs:
Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Not recruiting

3 1 1 1
Investigated Diseases:
- Pleural mesothelioma
Investigated Drugs:
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies